Sarkis Meterissian
- Oncology top 1%
- Cancer Research top 0.5%
- Molecular Biology top 5%
- Surgery top 2%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Atilla ÖmeroğluMorag ParkMargarita SouleimanovaGreg FinakSvetlana SadekovaFrançois PépinMichael HallettNicholas Bertos
- Topics
- Breast Cancer Treatment Studies (41 papers)Breast Lesions and Carcinomas (29 papers)Innovations in Medical Education (14 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Sarkis Meterissian
161 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Oncology 2.5k
- Cancer Research 1.8k
- Molecular Biology 1.5k
- Surgery 1.4k
- Pathology and Forensic Medicine 1.0k
Countries citing papers authored by Sarkis Meterissian
This map shows the geographic impact of Sarkis Meterissian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarkis Meterissian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarkis Meterissian more than expected).
Fields of papers citing papers by Sarkis Meterissian
This network shows the impact of papers produced by Sarkis Meterissian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarkis Meterissian. The network helps show where Sarkis Meterissian may publish in the future.
Co-authorship network of co-authors of Sarkis Meterissian
This figure shows the co-authorship network connecting the top 25 collaborators of Sarkis Meterissian. A scholar is included among the top collaborators of Sarkis Meterissian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarkis Meterissian. Sarkis Meterissian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 15 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 91 | |
| 12 | 17 | |
| 13 | 11 | |
| 14 | 13 | |
| 15 | 4 | |
| 16 | Support infrastructure available to Canadian residents completing post-graduate global health electives: current state and future directions | 1 |
| 17 | 20 | |
| 18 | 71 | |
| 19 | 98 | |
| 20 | 1 |
About Sarkis Meterissian
Sarkis Meterissian is a scholar working on Family Practice, Cancer Research and Oncology, having authored 167 papers that have together received 6.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (41 papers), Breast Lesions and Carcinomas (29 papers) and Innovations in Medical Education (14 papers). The work is most often cited by research in Family Practice (314 citations), Cancer Research (1.8k citations) and Oncology (2.5k citations). Sarkis Meterissian has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Atilla Ömeroğlu, Morag Park, Margarita Souleimanova, Greg Finak, Svetlana Sadekova, François Pépin, Michael Hallett, Nicholas Bertos, Haiying Chen and Gülbeyaz Ömeroğlu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.